Avobis Bio LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.avobisbio.com
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection
- Conditions
- Perianal Fistula Due to Crohn's Disease
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Avobis Bio, LLC
- Registration Number
- NCT06509828
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
Phase 2
Active, not recruiting
- Conditions
- Perianal FistulaCrohn's Disease
- Interventions
- Procedure: Seton Placement
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Avobis Bio, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT04847739
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸Office of Phillip Fleshner, MD, Los Angeles, California, United States
🇺🇸Stanford University, Redwood City, California, United States
News
No news found